Provided by Tiger Trade Technology Pte. Ltd.

Bioventus Inc.

13.67
+0.02000.15%
Post-market: 13.990.3200+2.34%19:30 EDT
Volume:642.89K
Turnover:8.81M
Market Cap:1.15B
PE:17.48
High:13.94
Open:13.69
Low:13.50
Close:13.65
52wk High:15.89
52wk Low:6.26
Shares:84.09M
Float Shares:33.47M
Volume Ratio:1.30
T/O Rate:1.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7821
EPS(LYR):0.3300
ROE:25.68%
ROA:5.49%
PB:5.04
PE(LYR):41.42

Loading ...

Bravura Solutions Signals Profitable Momentum In FY2026

TIPRANKS
·
Aug 26

Bravura Solutions (ASX:BVS) Is Down 8.1% After Announcing A$50m Buyback And Special Dividend – What's Changed

Simply Wall St.
·
Aug 24

Bioventus Earnings Call Highlights Growth Amid Review

TIPRANKS
·
Aug 21

Cantor Fitzgerald Reaffirms Their Buy Rating on Bioventus (BVS)

TIPRANKS
·
Aug 17

Bioventus Price Target Maintained with a $15.00/Share by Cantor Fitzgerald

Dow Jones
·
Aug 17

Bravura Solutions (ASX:BVS) Could Be 21% Overvalued As Buyback And Dividends Lift Sentiment

Simply Wall St.
·
Aug 17

Bravura Solutions Updates Market on Issue and Conversion of Unquoted Securities

TIPRANKS
·
Aug 17

Why Bravura Solutions (ASX:BVS) Is Up 28.2% After Launching a Major Buyback and Dividend Boost

Simply Wall St.
·
Aug 15

Bravura Solutions Reshapes Finance and Governance Leadership

TIPRANKS
·
Aug 14

Bravura Solutions (ASX:BVS) Shares Reflect Margin Gains But Churn Questions Linger

Simply Wall St.
·
Aug 13

Bravura Solutions Limited (BVS) Receives a Buy from Shaw and Partners

TIPRANKS
·
Aug 13

Macquarie Sticks to Their Hold Rating for Bravura Solutions Limited (BVS)

TIPRANKS
·
Aug 13

Bravura Solutions Updates Governance Framework to Align With ASX Best Practice

TIPRANKS
·
Aug 12

Bravura Solutions Declares AUD 0.15 Interim Dividend for Half-Year to June 2026

TIPRANKS
·
Aug 12

Barrington Adjusts Price Target on Bioventus to $18 From $14, Maintains Outperform Rating

MT Newswires Live
·
Aug 06

Bioventus Fiscal Q2 Adjusted Earnings, Revenue Rise; 2026 Guidance Reaffirmed

MT Newswires Live
·
Aug 05

Bioventus Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Bioventus Q2 Revenue Misses Estimates on Surgical Solutions Decline

Reuters
·
Aug 05

GUIDANCE: (BVS) Bioventus Expects Full Year 2026 Revenue Range 600M-$610M, vs. FactSet Est of $605.3M

MT Newswires Live
·
Aug 05

GUIDANCE: (BVS) Bioventus Expects 2026 Adjusted EPS Range $0.75 - $0.79, vs. FactSet Est of $0.78

MT Newswires Live
·
Aug 05